SCM-AGH

N/A

Report date: 2023/01/12 15:46:49

Base Information

Drug NameSCM-AGH

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapyCell and gene therapy > Cell therapy > Source of cells > Bone Marrow-derivedCell and gene therapy > Cell therapy > Donor > Allogeneic

Mechanisms of ActionStem cell replacements

TargetsNot applicable

Therapy Area/IndicationsDermatitis, AtopicPancreatitis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesScm Lifescience Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesScm Lifescience Co Ltd

Inactive CompaniesN/A

Active IndicationsDermatitis, AtopicPancreatitis

Inactive IndicationsN/A

Other Information

ATC CodeN/A